# US 2021/0330724 A1 · Cannabidiol alkaline composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330724 A1
- Document ID: US20210330724A1
- Status: Published application
- Kind: A1
- Application number: 16/483,249
- Filed: 2019-04-24
- Published: 2021-10-28
- Earliest claimed: 2018-08-28
- Assignees: Chirosyn Discovery Technologies Inc.
- Applicants: Chirosyn Discovery Technologies Inc.
- Inventors: SREEDHAR CHEEKOORI
- Web page: https://patentgrep.com/patent/US20210330724A1

## CPC

- A61K 36/3482: {Cannabis}
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 2/54: Mixing with gases
- A23L 29/015: {Inorganic compounds}
- A23L 29/03: {Organic compounds}
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

An aqueous alkaline composition comprising a cannabinoid which may be cannabidiol (CBD) used alone or in combination with other cannabinoids. An alkalizing agent which comprises pico size carbon particles is present in the composition, in an amount suitable for buffering the composition to a pH between about 7.5 and 9.5. The aqueous alkaline composition is stable and may be used in the preparation of a beverage or a pharmaceutical composition.

## Claims

### Claim 1

An aqueous composition comprising a cannabinoid and an alkalizing agent which comprises pico size carbon particles.

### Claim 2 (depends on 1)

The aqueous composition according to claim 1, wherein the alkalizing agent comprising pico size carbon particles is present in an amount suitable for buffering the composition to a pH between about 7.5 to 9.5, about 7.5 to 9.0, about 7.5 to 8.5, about 7.5 to 8.0, about 8 to 9.5, about 8 to 9.0, about 8 to 8.5, or about 8.5 to 9.5, about 8.5 to 9.0.

### Claim 3 (depends on 1, 2)

The aqueous composition according to claim 1 or 2, wherein the cannabinoid is present in an amount of about 1 to 100 mg/mL, about 10 to 100 mg/mL, about 20 to 100 mg/mL, about 30 to 100 mg/mL, about 35 to 100 mg/mL, about 40 to 100 mg/mL, about 45 to 100 mg/mL, about 50 to 100 mg/mL, about 55 to 100 mg/mL, about 60 to 100 mg/mL, or about 65 to 100 mg/mL.

### Claim 4 (depends on 1, 2, 3)

The aqueous composition according to any one of claims 1 to 3, wherein the cannabinoid is purified from a cannabis extract or the cannabinoid is synthesized.

### Claim 5 (depends on 1, 2, 3)

The aqueous composition according to any one of claims 1 to 3, wherein the cannabinoid is a cannabis extract enriched in cannabidiol (CBD).

### Claim 6 (depends on 1, 2, 3, 4, 5)

The aqueous composition according to any one of claims 1 to 5, wherein the cannabinoid comprises cannabidiol (CBD) and one or more of: tetrahydrocannabinol (Δ9-THC), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), and cannabidivarol (CBDV).

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The aqueous composition according to any one of claims 1 to 6, wherein the alkalizing agent is an oil-based material having pico size carbon particles suspended therein; optionally the oil-based material is Tall oil; optionally, the oil-based material is selected from the group consisting of hydrocarbon, higher fatty acid, higher alcohol, fatty acid ester of polyhydric alcohol, higher alcohol ether of polyhydric alcohol, polymer or copolymer of alkylene oxide, and a combination thereof.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The aqueous composition according to any one of claims 1 to 7, wherein the pico size carbon particles are from an organic source.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The aqueous composition according to any one of claims 1 to 8, further comprising a sugar or polyol, preferably the sugar is selected from the group consisting of mannitol, sucrose, glucose, fructose, high fructose corn syrup, invert syrup, refiner's syrup, corn syrup, maltose and high maltose syrups and mixtures thereof; more preferably the sugar or polyol is mannitol.

### Claim 10 (depends on 9)

The aqueous composition according to claim 9, wherein the sugar or polyol is present in an amount of about 2 to 20 mg/mL, about 3 to 20 mg/mL, about 4 to 20 mg/mL, about 5 to 20 mg/mL, about 6 to 20 mg/mL, about 7 to 20 mg/mL, or about 8 to 20 mg/mL.

### Claim 11 (depends on 9, 10)

The aqueous composition according to claim 9 or 10, further comprising a sweetener which is artificial or from a natural source; optionally the sweetener is a non-calorie sweetener selected from the group consisting of aspartame, saccharine, stevia, cyclamates, acetosulfam, L-aspartyl-L-phenylalanine lower alkyl ester sweeteners, L-aspartyl-D-alanine amides, L-aspartyl-D-serine amides, L-aspartyl-hydroxymethylalkane amide, L-aspartyl-1-hydroxyethylalkane amide, and mixtures thereof.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The aqueous composition according to any one of claims 1 to 11, further comprising a surfactant, preferably the surfactant is polysorbate 80 or Tween® 80.

### Claim 13 (depends on 12)

The aqueous composition according to claim 12, wherein the surfactant is present in an amount of about 1 to 30 mg/mL, about 2 to 30 mg/mL, about 3 to 30 mg/mL, about 4 to 30 mg/mL, about 5 to 30 mg/mL, about 6 to 30 mg/mL, about 7 to 30 mg/mL, about 8 to 30 mg/mL, about 9 to 30 mg/mL, about 10 to 30 mg/mL, about 11 to 30 mg/mL, or about 12 to 30 mg/mL.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The aqueous composition according to any one of claims 1 to 13, further comprising an ingredient selected from the group consisting of an emulsifier, a flavor agent which is artificial or from a natural source, a coloring agent which is artificial or from a natural source, caffeine, an antioxidant, a vitamin, a probiotic, a mineral, and a combination thereof.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The aqueous composition according to any one of claims 1 to 14, which is stable for a period of at least about 24 months.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The aqueous composition according to any one of claims 1 to 15, which is suitable for human consumption.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The aqueous composition according to any one of claims 1 to 15, which is suitable for medical administration to a patient in need of cannabinoid.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The aqueous composition according to any one of claims 1 to 17, wherein the cannabinoid is cannabidiol (CBD).

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The aqueous composition according to any one of claims 1 to 18, wherein the cannabinoid comprises a salt of the cannabinoid.

### Claim 20

An aqueous composition comprising cannabidiol (CBD) and an alkalizing agent which comprises pico size carbon particles.

### Claim 21 (depends on 20)

The aqueous composition according to claim 20, wherein the alkalizing agent comprising pico size carbon particles is present in an amount suitable for buffering the composition to a pH between about 7.5 to 9.5, about 7.5 to 9.0, about 7.5 to 8.5, about 7.5 to 8.0, about 8 to 9.5, about 8 to 9.0, about 8 to 8.5, or about 8.5 to 9.5, about 8.5 to 9.0.

### Claim 22 (depends on 20, 21)

The aqueous composition according to claim 20 or 21, wherein CBD is present in an amount of about 1 to 100 mg/mL, about 10 to 100 mg/mL, about 20 to 100 mg/mL, about 30 to 100 mg/mL, about 35 to 100 mg/mL, about 40 to 100 mg/mL, about 45 to 100 mg/mL, about 50 to 100 mg/mL, about 55 to 100 mg/mL, about 60 to 100 mg/mL, or about 65 to 100 mg/mL.

### Claim 23 (depends on 20, 21, 22)

The aqueous composition according to any one of claims 20 to 22, wherein CBD is purified from a cannabis extract or CBD is synthesized.

### Claim 24 (depends on 20, 21, 22, 23)

The aqueous composition according to any one of claims 20 to 23, wherein the alkalizing agent is an oil-based material having pico size carbon particles suspended therein; optionally the oil-based material is Tall oil; optionally, the oil-based material is selected from the group consisting of hydrocarbon, higher fatty acid, higher alcohol, fatty acid ester of polyhydric alcohol, higher alcohol ether of polyhydric alcohol, polymer or copolymer of alkylene oxide, and a combination thereof.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

A beverage comprising the aqueous composition as defined in any one of claims 1 to 24; optionally the beverage is a carbonated beverage.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

A pharmaceutical composition comprising the aqueous composition as defined in any one of claims 1 to 24; optionally the pharmaceutical composition comprises a pharmaceutically acceptable carrier or excipient.

### Claim 27

A pharmaceutical composition comprising a cannabinoid, an alkalizing agent which comprises pico size carbon particles, and water.

### Claim 28 (depends on 27)

The pharmaceutical composition according to claim 27, which has a pH between about 7.5 to 9.5, about 7.5 to 9.0, about 7.5 to 8.5, about 7.5 to 8.0, about 8 to 9.5, about 8 to 9.0, about 8 to 8.5, or about 8.5 to 9.5, about 8.5 to 9.0.

### Claim 29 (depends on 27, 28)

The pharmaceutical composition according to claim 27 or 28, wherein the cannabinoid is present in an amount of about 1 to 100 mg/mL, about 10 to 100 mg/mL, about 20 to 100 mg/mL, about 30 to 100 mg/mL, about 35 to 100 mg/mL, about 40 to 100 mg/mL, about 45 to 100 mg/mL, about 50 to 100 mg/mL, about 55 to 100 mg/mL, about 60 to 100 mg/mL, or about 65 to 100 mg/mL.

### Claim 30 (depends on 27, 28, 29)

The pharmaceutical composition according to any one of claims 27 to 29, wherein the cannabinoid is purified from a cannabis extract or the cannabinoid is synthesized.

### Claim 31 (depends on 27, 28, 29, 30)

The pharmaceutical composition according to any one of claims 27 to 30, wherein the cannabinoid is a cannabis extract enriched in cannabidiol (CBD).

### Claim 32 (depends on 27, 28, 29, 30, 31)

The pharmaceutical composition according to any one of claims 27 to 31, wherein the cannabinoid comprises cannabidiol (CBD) and one or more of: tetrahydrocannabinol (Δ9-THC), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), and cannabidivarol (CBDV).

### Claim 33 (depends on 27, 28, 29, 30, 31, 32)

The pharmaceutical composition according to any one of claims 27 to 32, wherein the alkalizing agent is an oil-based material having pico size carbon particles suspended therein; optionally, the oil-based material is selected from the group consisting of hydrocarbon, higher fatty acid, higher alcohol, fatty acid ester of polyhydric alcohol, higher alcohol ether of polyhydric alcohol, polymer or copolymer of alkylene oxide, and a combination thereof.

### Claim 34

A pharmaceutical composition comprising cannabidiol (CBD), an alkalizing agent which comprises pico size carbon particles, and water.

### Claim 35 (depends on 34)

The pharmaceutical composition according to claim 34, wherein the alkalizing agent comprising pico size carbon particles is present in an amount suitable for buffering the composition to a pH between about 7.5 to 9.5, about 7.5 to 9.0, about 7.5 to 8.5, about 7.5 to 8.0, about 8 to 9.5, about 8 to 9.0, about 8 to 8.5, or about 8.5 to 9.5, about 8.5 to 9.0.

### Claim 36 (depends on 34, 35)

The pharmaceutical composition according to claim 34 or 35, wherein CBD is present in an amount of about 1 to 100 mg/mL, about 10 to 100 mg/mL, about 20 to 100 mg/mL, about 30 to 100 mg/mL, about 35 to 100 mg/mL, about 40 to 100 mg/mL, about 45 to 100 mg/mL, about 50 to 100 mg/mL, about 55 to 100 mg/mL, about 60 to 100 mg/mL, or about 65 to 100 mg/mL.

### Claim 37 (depends on 34, 35, 36)

The pharmaceutical composition according to any one of claims 34 to 36, wherein CBD is purified from a cannabis extract or CBD is synthesized.

### Claim 38 (depends on 34, 35, 36, 37)

The pharmaceutical composition according to any one of claims 34 to 37, wherein the alkalizing agent is an oil-based material having pico size carbon particles suspended therein; optionally the oil-based material is Tall oil; optionally, the oil-based material is selected from the group consisting of hydrocarbon, higher fatty acid, higher alcohol, fatty acid ester of polyhydric alcohol, higher alcohol ether of polyhydric alcohol, polymer or copolymer of alkylene oxide, and a combination thereof.

### Claim 39 (depends on 34, 35, 36, 37, 38)

The pharmaceutical composition according to any one of claims 34 to 38, further comprising a pharmaceutically acceptable carrier.

### Claim 40

A method of preparing an aqueous composition comprising a cannabinoid, the method comprising:
(a) providing the cannabinoid;
(b) providing an alkalizing agent which comprises pico size carbon particles;
(c) mixing the cannabinoid and the alkalizing agent and stirring the mixture for a period of time; and
(d) adding water to the mixture for a period of time to obtain the aqueous composition.

### Claim 41 (depends on 40)

The method according to claim 40, wherein step (a) comprises one or more of:
(a1) extracting the cannabinoid from a cannabis extract;
(a2) submitting a cannabis extract to a cannabidiol (CBD)-enriched process to obtain a cannabis extract enriched with CBD; and
(a3) providing a mixture of CBD with one or more of tetrahydrocannabinol (Δ9-THC), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), and cannabidivarol (CBDV).

### Claim 42 (depends on 40, 41)

The method according to claim 40 or 41, wherein step (b) comprises providing an oil-based material having pico size carbon particles suspended therein; optionally the oil-based material is tall oil.

### Claim 43 (depends on 40, 41, 42)

The method according to any one of claims 40 to 42, wherein step (c) is performed at room temperature and/or the mixture is stirred for about 30 minutes.

### Claim 44 (depends on 40, 41, 42, 43)

The method according to any one of claims 40 to 43, wherein at step (d) the mixture is stirred for about 30 minutes.

### Claim 45 (depends on 40, 41, 42, 43, 44)

The method according to any one of claims 40 to 44, further comprising storing the aqueous alkaline composition for future use.

### Claim 46 (depends on 40, 41, 42, 43, 44, 45)

The method according to any one of claims 40 to 45, wherein the aqueous composition has a pH between about 7.5 to 9.5, about 7.5 to 9.0, about 7.5 to 8.5, about 7.5 to 8.0, about 8 to 9.5, about 8 to 9.0, about 8 to 8.5, or about 8.5 to 9.5, about 8.5 to 9.0.

### Claim 47 (depends on 40, 41, 42, 43, 44, 45, 46)

The method according to any one of claims 40 to 46, wherein the cannabinoid is present in an amount of about 1 to 100 mg/mL, about 10 to 100 mg/mL, about 20 to 100 mg/mL, about 30 to 100 mg/mL, about 35 to 100 mg/mL, about 40 to 100 mg/mL, about 45 to 100 mg/mL, about 50 to 100 mg/mL, about 55 to 100 mg/mL, about 60 to 100 mg/mL, or about 65 to 100 mg/mL.

### Claim 48 (depends on 40, 41, 42, 43, 44, 45, 46, 47)

The method according to any one of claims 40 to 47, wherein the alkalizing agent is an oil-based material having pico size carbon particles suspended therein; optionally the oil-based material is Tall oil; optionally, the oil-based material is selected from the group consisting of hydrocarbon, higher fatty acid, higher alcohol, fatty acid ester of polyhydric alcohol, higher alcohol ether of polyhydric alcohol, polymer or copolymer of alkylene oxide, and a combination thereof.

### Claim 49 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method according to any one of claims 40 to 48, wherein the cannabinoid is cannabidiol (CBD).

### Claim 50

A method of preparing an aqueous composition comprising cannabidiol (CBD), the method comprising:
(a) providing CBD;
(b) providing an alkalizing agent which comprises pico size carbon particles;
(c) mixing CBD and the alkalizing agent and stirring the mixture for a period of time; and
(d) adding water to the mixture for a period of time to obtain the aqueous composition.

### Claim 51 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

A method of treating a patient in need of a cannabinoid, comprising administering to the patient a pharmaceutical composition as defined in any one of claims 26 to 39.

### Claim 52

A method of treating a patient in need of a cannabinoid, comprising administering to the patient a pharmaceutical composition comprising a cannabinoid, an alkalizing agent which comprises pico size carbon particles, and water.

### Claim 53

A method of treating a patient in need of cannabidiol (CBD), comprising administering to the patient a pharmaceutical composition comprising CBD, an alkalizing agent which comprises pico size carbon particles, and water.

### Claim 54 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

Use of a pharmaceutical composition as defined in any one of claims 26 to 39, for treating a patient in need of a cannabinoid.

### Claim 55

Use of a pharmaceutical composition comprising a cannabinoid, an alkalizing agent which comprises pico size carbon particles, and water, for treating a patient in need of a cannabinoid.

### Claim 56

Use of a pharmaceutical composition comprising a cannabinoid, an alkalizing agent which comprises pico size carbon particles, and water, in the manufacture of a medicament for treating a patient in need of cannabinoid.

### Claim 57 (depends on 56)

The use of claim 56, wherein the medicament is suitable for oral administration, for injection, for administration by spraying, or for administration by pumping.

### Claim 58 (depends on 55, 56, 57)

The use according to any one of claims 55 to 57, wherein the cannabinoid is cannabidiol (CBD).

### Claim 59 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The pharmaceutical composition according to any one of claims 26 to 39, for use in the treatment of a patient in need of cannabinoid.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The aqueous composition according to any one of claims 1 to 24, for use in the preparation of a beverage.

### Claim 61

A kit comprising:
a cannabinoid;
an alkalizing agent which comprises pico size carbon particles;
water; and
instructions for use.

### Claim 62

A kit comprising:
cannabidiol (CBD);
an alkalizing agent which comprises pico size carbon particles;
water; and
instructions for use.

### Claim 63

A kit comprising:
a mixture comprising cannabidiol (CBD) and an alkalizing agent which comprises pico size carbon particles, optionally the mixture is suspended in an emulsifier;
water; and
instructions for use.

### Claim 64 (depends on 61, 62, 63)

The kit according to any one of claims 61 to 63, wherein the use is for the preparation of a medicament or for the preparation of a beverage.
